| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 12/24/2009 | US20090318547 Glucopyranosyl-substituted difluorobenzyl-benzene derivates, medicaments containing such compounds, their use and process for their manufacture |
| 12/24/2009 | US20090318544 Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide |
| 12/24/2009 | US20090318532 Compounds and methods for modulating expression of ptp1b |
| 12/24/2009 | US20090318524 Bicyclic tetrahydropyrrole compounds |
| 12/24/2009 | US20090318502 Pharmaceutical Compositions Comprising a Hypoglycemic Agent and Methods of Using Same |
| 12/24/2009 | US20090318489 Aporphine compounds and pharmaceutical use thereof |
| 12/24/2009 | US20090318484 Inhibitors of JNK |
| 12/24/2009 | US20090318477 Chemical compounds |
| 12/24/2009 | US20090318474 Pyridine and pyrimidine derivatives as mglur 2 antagonists |
| 12/24/2009 | US20090318465 Method for identifying compounds that act as insulin-sensitizers |
| 12/24/2009 | US20090318452 INHIBITORS OF p38 |
| 12/24/2009 | US20090318439 5-furopyridinone substituted indazoles |
| 12/24/2009 | US20090318412 Tricyclic heterocyclic compound and use thereof |
| 12/24/2009 | US20090318406 Substituted oxindole derivatives and their use as vasopressin and/or oxytocin receptor ligands |
| 12/24/2009 | US20090318377 Medicagenic acid saponin and uses thereof |
| 12/24/2009 | US20090318365 Metastin derivatives and use thereof |
| 12/24/2009 | US20090318347 Novel compounds and their effects on feeding behaviour |
| 12/24/2009 | US20090317496 Method for Preventing and Treating the Disease Caused by Vascular Damage and the Use Thereof |
| 12/24/2009 | US20090317389 Fusion molecules and methods for treatment of immune diseases |
| 12/24/2009 | US20090317376 Compositions And Methods For Lipo Modeling |
| 12/24/2009 | US20090317372 Small molecules for the reduction of high blood glucose level |
| 12/24/2009 | US20090317332 Human g protein-coupled receptor and modulators thereof for the treatment of obesity and conditions related thereto |
| 12/23/2009 | WO2009155389A1 Triazolopyridine compounds useful as kinase inhibitors |
| 12/23/2009 | WO2009155309A1 Substituted cyanopyrrolidine derivatives |
| 12/23/2009 | WO2009154697A2 Disc-1 pathway activators in the control of neurogenesis |
| 12/23/2009 | WO2009154573A1 Modulators of stat3 signalling |
| 12/23/2009 | WO2009154280A1 Agent for preventing excessive appetite |
| 12/23/2009 | WO2009154276A1 Crystal of spiroketal derivative, and process for production thereof |
| 12/23/2009 | WO2009154230A1 Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis |
| 12/23/2009 | WO2009154132A1 Spirodiamine-diarylketoxime derivative |
| 12/23/2009 | WO2009153960A1 Glycosylated glp-1 peptide |
| 12/23/2009 | WO2009153662A1 New uses of lactic acid bacteria and bifidobacteria |
| 12/23/2009 | WO2009153569A2 Cb1 receptor modulators |
| 12/23/2009 | WO2009152909A1 Quinoxalinedione derivatives |
| 12/23/2009 | WO2009152665A1 A pharmaceutical composition for treating diabetes |
| 12/23/2009 | WO2009074969A3 Spingosine-1-phosphate, analogues and antagonists for use as medicaments |
| 12/23/2009 | EP2135618A2 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 12/23/2009 | EP2135611A1 Pregn-5-en-20-yne-3,7,17-triol derivatives for use in therapy |
| 12/23/2009 | EP2135606A1 Anti-fatigue agent |
| 12/23/2009 | EP2135604A1 Infusion preparation for cancer patient |
| 12/23/2009 | EP2135603A2 Compositions and methods for increasing insulin sensitivity |
| 12/23/2009 | EP2135517A1 Composition for promotion of bone growth and maintenance of bone health |
| 12/23/2009 | EP2134705A1 Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors |
| 12/23/2009 | EP2134348A1 Weekly administration of dipeptidyl peptidase inhibitors |
| 12/23/2009 | EP1959951B1 Heteroaryl substituted piperidine derivatives as l-cpt1 inhibitors |
| 12/23/2009 | EP1879564B1 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
| 12/23/2009 | EP1796657B1 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 12/23/2009 | EP1682550B1 Substituted naphthyridinone derivatives |
| 12/23/2009 | EP1523475B1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| 12/23/2009 | EP1485343B1 Amorphous hmg-coa reductase inhibitors of desired particle size |
| 12/23/2009 | EP1421174B1 Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof |
| 12/23/2009 | EP1259487B1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 12/23/2009 | EP1232757B1 Agents for diseases in association with decrease in bone mass |
| 12/23/2009 | CN101611032A Thienyl-containing glycopyranosyl derivatives as antidiabetics |
| 12/23/2009 | CN101611027A Indol-2-yl-piperazin-1-yl-methanone derivatives |
| 12/23/2009 | CN101611023A 1-phenyl 1-thio-d-glucitol derivative |
| 12/23/2009 | CN101610998A 5 -amido- (ih- indol- 2 -yl) piperazin-1-yl-methanone derivatives as histamine h3 receptor ligands |
| 12/23/2009 | CN101610790A Novel compositions and uses thereof |
| 12/23/2009 | CN101610766A Pharmaceutical composition containing phenanthrenequinone-based compound for intestine delivery system |
| 12/23/2009 | CN101610760A Treatment of cachexia |
| 12/23/2009 | CN101608172A Transformant for reducing weight and fat and preparation method thereof |
| 12/23/2009 | CN101607979A Pentacylic triterpanes-vitamin C conjugates as well as preparation method and medical application thereof |
| 12/23/2009 | CN101607080A Oral drug for treating diabetes and preparation method thereof |
| 12/23/2009 | CN101607078A Traditional Chinese medicine five-feng amino acid nutritional plaster matrix and preparation of externally applied plaster of matrix |
| 12/23/2009 | CN101607073A Method for cultivating Chinese medicinal health care product ganoderma and health preservation liquid thereof by conventional biotechnology |
| 12/23/2009 | CN101607066A Chinese medicinal composition for reducing cholesterol and triglycercide |
| 12/23/2009 | CN101607063A Medicinal composition for lowering fat and protecting liver and preparation method thereof |
| 12/23/2009 | CN101607051A Traditional Chinese medicine composition for losing weight and preparation method thereof |
| 12/23/2009 | CN101607031A Medicated wine for curing and preventing diabetes mellitus, preparation method and application method thereof |
| 12/23/2009 | CN101607023A Method for curing hyperlipemia by taking foot bath in traditional Chinese medicine solution |
| 12/23/2009 | CN101607008A Method for curing senile hyperlipemia by soaking feet in traditional Chinese medical liquid |
| 12/23/2009 | CN101606999A Traditional Chinese medicine preparation for treating type diabetes B lower limb atherosclerosis |
| 12/23/2009 | CN101606986A Composite and drug thereof with blood-sugar reducing function |
| 12/23/2009 | CN101606978A Blood-sugar reducing tea and preparation method thereof |
| 12/23/2009 | CN101606965A Fat-reducing liver-protecting tea and preparation method thereof |
| 12/23/2009 | CN101606955A Tamariskoid spikemoss herb effective part for reducing blood lipid, extraction method and application thereof, and extraction method of amentoflavone |
| 12/23/2009 | CN101606942A Nutritional supplement for relieving sports fatigue |
| 12/23/2009 | CN101606939A Fat-soluble vitamin freeze-dried powder needle and preparation method thereof |
| 12/23/2009 | CN101606936A Medicinal composition for treating diabetes |
| 12/23/2009 | CN101606928A Application of compound of amentoflavone in preparing hypolipidemic medicament |
| 12/23/2009 | CN101606927A Application of compound of amentoflavone in preparing hypoglycemic medicament |
| 12/23/2009 | CN101606740A Method for preparing sugarless mulberry leaf beverage and application thereof |
| 12/23/2009 | CN101606698A Natural colour viscera-nourishing nutritional noodles and preparation method |
| 12/23/2009 | CN101606694A Natural colour blood fat-lowering, blood glucose-lowering and blood pressure-lowering porridge and preparation method |
| 12/23/2009 | CN101606693A Natural colour lipid-lowering and weight-losing porridge and preparation method |
| 12/23/2009 | CN101606692A Natural colour viscera-nourishing nutritional porridge and preparation method |
| 12/23/2009 | CN101606665A Phyllanthus emblica powder and processing method thereof |
| 12/23/2009 | CN101606664A Phyllanthus emblica powder and processing method thereof |
| 12/23/2009 | CN101606663A Processing method for olive powder |
| 12/23/2009 | CN100572380C Berberine ion pair compound, preparing method and drug containing same |
| 12/23/2009 | CN100572375C Spiro-benzodioxoles and their use as CB1 antagonists |
| 12/23/2009 | CN100572374C Puerarin derivatives and their medical uses |
| 12/23/2009 | CN100572372C Salvianolic acid M and rosmarinic acid as aldose reductase inhibitor in sage |
| 12/23/2009 | CN100571786C Vaccine for preventing and/or treating autoimmune disease |
| 12/23/2009 | CN100571783C Glipizide controlled release tablets and preparation method thereof |
| 12/23/2009 | CN100571776C Association between a PPAR ligand and an antioxidant agent and use thereof for treating obesity |
| 12/23/2009 | CN100571740C Traditional Chinese medicine composition with hypoglycemic and antilipemic function and making method and application |
| 12/23/2009 | CN100571726C Medicinal compositions |
| 12/23/2009 | CN100571708C Medicinal composition having cooperative action |
| 12/23/2009 | CN100571526C Health tea |